Iron Sucrose Dosing for Iron Deficiency Anemia
For this 35-year-old female with hemoglobin 7.1 g/dL, administer iron sucrose 200 mg diluted in 100 mL normal saline infused over 15 minutes, given on 5 different occasions over a 14-day period (total dose 1000 mg). 1
Dosing Rationale
This patient fits the profile of a non-dialysis dependent patient with iron deficiency anemia. The FDA-approved Venofer (iron sucrose) label provides clear guidance for this scenario 1:
- Dose per infusion: 200 mg iron sucrose
- Dilution: Maximum 100 mL of 0.9% normal saline
- Infusion time: 15 minutes minimum
- Frequency: 5 separate doses over 14 days
- Total treatment course: 1000 mg elemental iron
Administration Details
Each infusion should be given as follows:
- Dilute 200 mg (10 mL of iron sucrose, since each mL contains 20 mg elemental iron) in 100 mL normal saline 1
- Infuse over at least 15 minutes
- Monitor the patient during infusion and for at least 30 minutes after completion 1
Alternative slower injection option: 200 mg can be given undiluted as a slow IV injection over 2-5 minutes, though infusion is generally preferred for safety monitoring 1
Treatment Schedule Example
A practical 14-day schedule would be:
- Days 1,4,7,10, and 14: Each receiving 200 mg iron sucrose infusion
- This completes the 1000 mg total treatment course
Expected Response
Based on research evidence, you should expect:
- Mean hemoglobin increase of approximately 3.2 g/dL at 6 months follow-up 2
- Significant improvement in hemoglobin within 1-3 months, with levels rising from baseline to approximately 10.4 g/dL initially and 11.2 g/dL at 6-12 months 3
- Serum ferritin should increase substantially, from low baseline to approximately 224-298 ng/mL 3, 4
Safety Monitoring
Critical safety considerations:
- Monitor for hypersensitivity reactions during and for 30 minutes post-infusion 1
- Serious anaphylactic-type reactions, though rare, can occur 1
- Have resuscitation equipment available
- Stop infusion immediately if any signs of intolerance develop 1
Follow-up Monitoring
- Recheck hemoglobin at 4 weeks after completing the course to assess response 5
- Continue monitoring every 4 weeks until hemoglobin normalizes 5
- After normalization, check blood count every 3 months for 12 months, then every 6 months for 2-3 years 5
Important Caveats
Treatment may be repeated if iron deficiency recurs 1. However, approximately 30% of patients may not respond adequately and could require blood transfusion 3. Non-response should prompt investigation for:
- Ongoing blood loss
- Malabsorption
- Chronic inflammatory conditions
- Underlying malignancy (response to IV iron correlates with tumor response in cancer patients) 3
Alternative high-dose option: While the standard FDA-approved regimen is preferred, there is limited experience with a single 500 mg infusion diluted in 250 mL normal saline over 3.5-4 hours on Day 1 and Day 14 1. However, the standard 5-dose regimen over 14 days is better established and recommended.
The 2024 expert consensus guidelines note that newer formulations like ferric carboxymaltose and low molecular weight iron dextran allow single 1000 mg infusions 6, but iron sucrose specifically requires the divided dosing schedule outlined above per its FDA label 1.